Helicobacter Pylori Infection
📧 Sign up to get email alerts when something new happens for Helicobacter Pylori Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori Infection [Phase 4]
A Phase 4 trial completed evaluating high-dose ilaprazole with amoxicillin as dual therapy for Helicobacter pylori infection.
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Concomitant, Sequential, and Standard Triple Therapy for H. Pylori Infection [Phase 4]
This Phase 4 trial evaluated concomitant, sequential, and standard triple therapy regimens for Helicobacter pylori infection. Results have b…
-
FDA approval · 2015-09-28FDA Approved: CLARITHROMYCIN — Original Application (Solaris Pharma Corporation)
FDA approved an Original Application (ANDA) for Clarithromycin from Solaris Pharma Corporation, establishing a generic version of clarithrom…
-
CLINICAL_TRIALS withdrawal · 2015-09-24Clinical Trial Update: Helicobacter in The Gambia (Part 2)
Clinical trial NCT00467155 in The Gambia investigating Helicobacter pylori has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: Comparison of Dexlansoprazole-based Triple and Rabeprazole-based Triple Therapies for Helicobacter Pylori Infection [Phase 4]
Phase 4 trial comparing dexlansoprazole-based triple therapy to rabeprazole-based triple therapy for Helicobacter pylori infection; the stud…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-09-01Clinical Trial Update: Resistance of Helicobacter Pylori to Antibiotics in Children
A completed clinical trial (NCT01902589) investigated antibiotic resistance of Helicobacter pylori in pediatric patients, with results now a…
-
CLINICAL_TRIALS trial_result · 2015-08-27Clinical Trial Update: Efficacy and Safety of Basic Triple Therapy Including Ilaprazole on the First Line Eradication Treatment of H.Pylori
This clinical trial update reports on the efficacy and safety of a basic triple therapy including ilaprazole for first-line eradication of H…
-
CLINICAL_TRIALS withdrawal · 2015-08-20Clinical Trial Update: Helicobacter Pylori and Iron Deficiency: Prevalence of Association and Effect of Therapy [Phase 4]
Phase 4 clinical trial evaluating the association between Helicobacter pylori infection and iron-deficiency anemia and the impact of therapy…
-
FDA approval · 2015-08-19FDA Approved: OMEPRAZOLE — Original Application (Aurobindo Pharma Limited)
The FDA approved Aurobindo Pharma Limited's original application for a generic omeprazole product.
-
CLINICAL_TRIALS trial_result · 2015-08-17Clinical Trial Update: Lactobacillus Reuteri in Management of Helicobacter Pylori Infection in Dyspeptic Patients [NA]
A completed clinical trial evaluated Lactobacillus reuteri as an adjunct in managing Helicobacter pylori infection in dyspeptic patients; re…
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: Helicobacter Pylori and the Long-term Risk of Peptic Ulcer Bleeding
A completed clinical trial update examining whether Helicobacter pylori infection influences the long-term risk of peptic ulcer bleeding.
-
FDA approval · 2015-07-27FDA Approved: CLARITHROMYCIN — Supplemental Application (Chartwell RX, LLC.)
FDA approved Chartwell RX, LLC.'s supplemental application for Clarithromycin (generic) under the ANDA process, resulting in approval of a g…
-
CLINICAL_TRIALS trial_result · 2015-07-08Clinical Trial Update: Sequential Therapy Versus Quadruple Therapy as Second Line Treatment After Failure of the Standard Triple Therapy for H Pylori Infection [Phase 3]
A Phase 3 trial compared sequential therapy versus quadruple therapy as second-line treatment after failure of standard triple therapy for H…
-
FDA approval · 2015-07-01FDA Approved: CLARITHROMYCIN — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for clarithromycin from Sandoz Inc, indicating continued/expanded approval for generic use of the dr…
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: Five Days Quadruple and Clarithromycin Containing Triple Therapy as Treatment for Helicobacter Pylori Eradication [NA]
This clinical trial update reports a completed study evaluating a five-day quadruple therapy and a clarithromycin-containing triple therapy …
-
CLINICAL_TRIALS trial_result · 2015-05-08Clinical Trial Update: Helicobacter in The Gambia (Part 1)
This entry notes the completion of a clinical trial in The Gambia studying Helicobacter pylori infection.
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: Comparison of Conventional Triple Therapy Versus Sequential Therapy for H. Pylori in Peptic Ulcer Disease: Prospective Randomized Trial [Phase 4]
Phase 4 randomized trial comparing conventional triple therapy with sequential therapy for Helicobacter pylori in peptic ulcer disease.
-
CLINICAL_TRIALS trial_result · 2015-04-10Clinical Trial Update: High Dose PPI Triple Therapy Versus Sequential Therapy for Helicobacter Pylori Eradication [Phase 4]
Phase 4 study comparing high-dose PPI triple therapy versus sequential therapy for Helicobacter pylori eradication in patients with dyspepsi…
-
FDA approval · 2015-04-02FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved a supplemental application for rabeprazole sodium from Torrent Pharmaceuticals Limited under ANDA 202376, indicating a post…
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: Efficacy on Helicobacter Pylori Eradication With Two Antibiotic Regimens [Phase 4]
Phase 4 clinical trial comparing two antibiotic regimens for Helicobacter pylori eradication has completed.
-
FDA approval · 2015-03-20FDA Approved: OMEPRAZOLE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for omeprazole from Apotex Corp., authorizing a generic version of the drug.
-
FDA approval · 2015-03-16FDA Approved: OMEPRAZOLE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for omeprazole submitted by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2015-03-06FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
FDA approved a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole) submitted by AmerisourceBergen, under NDA 022032.
-
FDA approval · 2015-02-25FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA has approved a supplemental application for Pantoprazole Sodium from Torrent Pharmaceuticals Limited, resulting in the approval of the g…
-
CLINICAL_TRIALS trial_result · 2015-02-24Clinical Trial Update: Randomized Study on Efficacy of Gemifloxacin-based Regimen for Helicobacter Pylori Infection [Phase 3]
A randomized Phase 3 study is evaluating a gemifloxacin-based regimen for Helicobacter pylori infection; the current status of the trial is …